D. Ibañez

发表

Socioeconomic risk factors and musculoskeletal disability.

E. Badley, D. Ibañez, Badley Em, 1994, The Journal of rheumatology.

Systemic Lupus Erythematosus Risk Factors for Development of Coronary Artery Disease in Women with NIKPOUR and DAFNA

D. Gladman, M. Urowitz, R. Goldberg, 2009 .

Systemic lupus erythematosus disease activity index 2000.

D. Gladman, M. Urowitz, D. Ibañez, 2002, The Journal of rheumatology.

Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations

D. Gladman, M. Urowitz, M. Urowitz, 2004, Lupus.

Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors.

D. Gladman, M. Urowitz, D. Ibañez, 2007, The Journal of rheumatology.

Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity.

D. Gladman, M. Urowitz, I. Blasutig, 2013, Clinical biochemistry.

Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period

D. Gladman, M. Urowitz, D. Ibañez, 2012, Arthritis care & research.

Association of killer cell immunoglobulin–like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus

M. Urowitz, V. Chandran, D. Ibañez, 2008, Lupus.

The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: a nested case-control study of inception patients

M. Urowitz, D. Ibañez, D. Gladman, 2007, Lupus.

Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.

D. Gladman, M. Urowitz, D. Ibañez, 2006, The Journal of rheumatology.

The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed?

D. Gladman, M. Urowitz, D. Ibañez, 2003, Arthritis and rheumatism.

articleVariability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus : a longitudinal cohort study

D. Gladman, M. Urowitz, D. Ibañez, 2015 .

American College of Rheumatology Criteria at Inception, and Accrual over 5 Years in the SLICC Inception Cohort

I. Bruce, D. Gladman, C. Gordon, 2014, The Journal of Rheumatology.

Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study

D. Gladman, M. Urowitz, D. Ibañez, 2011, Arthritis research & therapy.

Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study

D. Gladman, M. Urowitz, D. Ibañez, 2010, Arthritis research & therapy.

Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus

M. Urowitz, D. Ibañez, D. Gladman, 2006, Lupus.

Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus.

D. Gladman, M. Urowitz, D. Ibañez, 2005, Arthritis and rheumatism.

The effect of pregnancy on lupus nephritis.

D. Gladman, M. Urowitz, D. Ibañez, 2004, Arthritis and rheumatism.

Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.

D. Gladman, M. Urowitz, D. Ibañez, 2007, The Journal of rheumatology.

Optimal Frequency of Visits for Patients with Systemic Lupus Erythematosus to Measure Disease Activity Over Time

D. Gladman, M. Urowitz, D. Ibañez, 2011, The Journal of Rheumatology.

Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate.

D. Ibañez, J. Marenco, M. Gonzalez-gay, 1998, Arthritis and rheumatism.

Henoch-schönlein purpura as clinical presentation of a myelodysplastic syndrome

A. Regueira, D. Ibañez, R. Blanco, 1997, Clinical Rheumatology.

D. Gladman, M. Urowitz, D. Ibañez, 2010 .

Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.

D. Gladman, M. Urowitz, D. Ibañez, 2003, The Journal of rheumatology.

Recommendations for Frequency of Visits to Monitor Systemic Lupus Erythematosus in Asymptomatic Patients: Data from an Observational Cohort Study

D. Gladman, M. Urowitz, D. Ibañez, 2013, The Journal of Rheumatology.

Clinically active serologically quiescent systemic lupus erythematosus.

D. Gladman, M. Urowitz, D. Ibañez, 2003, The Journal of rheumatology.

Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.

D. Gladman, E. Silverman, D. Ibañez, 2008, Arthritis and rheumatism.

Prolonged remission in systemic lupus erythematosus.

I. Bruce, D. Gladman, M. Urowitz, 2005, The Journal of rheumatology.

Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome

D. Gladman, M. Urowitz, D. Ibañez, 2010, The Journal of Rheumatology.

The Journal of Rheumatology Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, D. Ibañez, 2016 .

Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus.

D. Gladman, M. Urowitz, Sindhu R. Johnson, 2006, The Journal of rheumatology.

Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE.

D. Gladman, M. Urowitz, D. Ibañez, 2005, The Journal of rheumatology.

Prolonged Clinical Remission in Patients with Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, D. Ibañez, 2014, The Journal of Rheumatology.

Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, J. Wither, 2015, The Journal of Rheumatology.

The effect of menopause on disease activity in systemic lupus erythematosus.

D. Gladman, M. Urowitz, D. Ibañez, 2006, The Journal of rheumatology.

Assessment of a New Treatment Schedule in Sublingual Immunotherapy. A Randomised Double-Blind Placebo-Controlled Multicentre Study

D. Ibañez, A. Nieto, M. Boquete, 2006 .

Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus

D. Gladman, M. Urowitz, D. Ibañez, 2011, Arthritis care & research.

Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities.

I. Bruce, D. Gladman, M. Urowitz, 2003, The Journal of rheumatology.

Ondansetron prevents refractory and severe methotrexate-induced nausea in rheumatoid arthritis.

D. Ibañez, M. Gonzalez-gay, R. Blanco, 1998, British journal of rheumatology.

Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression.

H. Moldofsky, D. Gladman, M. Urowitz, 2006, The Journal of rheumatology.

Summarizing disease features over time: II. Variability measures of SLEDAI-2K.

D. Gladman, M. Urowitz, D. Ibañez, 2007, The Journal of rheumatology.

Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality.

D. Ibañez, V. Abraira, R. Blanco, 1997, The Journal of rheumatology.

The clinical spectrum of osteoarticular tuberculosis in non-human immunodeficiency virus patients in a defined area of northwestern Spain (1988-1997).

D. Ibañez, M. González‐Gay, J. Mayo, 1999, Clinical and experimental rheumatology.

Osteoarticular complications of brucellosis in an Atlantic area of Spain.

D. Ibañez, M. González‐Gay, M. García-País, 1999, The Journal of rheumatology.

Occupational asthma due to different spices

D. Ibañez, J. Sastre, C. Lahoz, 1996, Allergy.

The clinical spectrum of severe septic bursitis in northwestern Spain: a 10 year study.

D. Ibañez, M. Gonzalez-gay, M. García-País, 1999, The Journal of rheumatology.

An Outcome Analysis of 100 Women After Explantation of Silicone Gel Breast Implants

D. Ibañez, S. Lugowski, Dennis C. Smith, 1997, Annals of plastic surgery.

Magnetic resonance imaging: a useful technique in the diagnosis and follow up of focal myositis.

D. Ibañez, R. Blanco, M. González‐Gay, 1996, Annals of the rheumatic diseases.

Henoch-Schönlein purpura as a clinical presentation of small cell lung cancer.

D. Ibañez, L. A. Pérez de Llano, R. Blanco, 1997, Clinical and experimental rheumatology.

Paradoxical and persistent renal impairment in Henoch-Schönlein purpura after high-dose immunoglobulin therapy.

D. Ibañez, R. Blanco, M. González‐Gay, 1997, Nephron.

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.

I. Bruce, D. Gladman, M. Urowitz, 2003, Arthritis and rheumatism.

Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort.

I. Bruce, D. Gladman, M. Urowitz, 2008, Arthritis and rheumatism.

SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement

D. Gladman, M. Urowitz, D. Ibañez, 2015, The Journal of Rheumatology.

Accrual of organ damage over time in patients with systemic lupus erythematosus.

D. Gladman, M. Urowitz, P. Rahman, 2003, The Journal of rheumatology.

Changes in Quality of Life in the First 5 Years of Disease in a Multicenter Cohort of Patients With Systemic Lupus Erythematosus

I. Bruce, M. Urowitz, E. Ginzler, 2014, Arthritis care & research.

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Enhances the Ability of SLE Responder Index to Identify Responders in Clinical Trials

D. Gladman, M. Urowitz, D. Ibañez, 2011, The Journal of Rheumatology.

Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort

I. Bruce, D. Gladman, M. Urowitz, 2012, Arthritis care & research.

Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months.

D. Gladman, M. Urowitz, D. Ibañez, 2012, Rheumatology.

Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50

D. Gladman, M. Urowitz, D. Ibañez, 2011, The Journal of Rheumatology.

Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus

B. Tom, D. Gladman, M. Urowitz, 2008, The Journal of Rheumatology.

Myocardial Perfusion Imaging in Assessing Risk of Coronary Events in Patients with Systemic Lupus Erythematosus

I. Bruce, D. Gladman, M. Urowitz, 2009, Journal of Rheumatology.

D. Gladman, M. Urowitz, D. Ibañez, 2011 .

Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, D. Ibañez, 2016, The Journal of Rheumatology.

High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus.

D. Gladman, M. Urowitz, D. Ibañez, 2012, Arthritis and rheumatism.

Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients.

D. Gladman, M. Urowitz, D. Ibañez, 2012, Rheumatology.

Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort

I. Bruce, D. Gladman, M. Urowitz, 2007, Lupus.

Is Overall Improvement SLEDAI-2K Does Not Conceal Worsening in a Particular System When There

D. Gladman, M. Urowitz, D. Ibañez, 2015 .

Disease Activity Index 2000 Responder Index 50 Development and Initial Validation of the Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, D. Ibañez, 2011 .

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50: A Reliable Index for Measuring Improvement in Disease Activity

Claire M. Riddell, D. Gladman, M. Urowitz, 2011, The Journal of Rheumatology.

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus

D. Gladman, M. Urowitz, P. Fortin, 2010, Arthritis care & research.

Time to Recovery from Proteinuria in Patients with Lupus Nephritis Receiving Standard Treatment

D. Gladman, M. Urowitz, D. Ibañez, 2014, The Journal of Rheumatology.

The Effect of Lupus Nephritis on Pregnancy Outcome and Fetal and Maternal Complications

D. Gladman, M. Urowitz, M. Urowitz, 2010, The Journal of Rheumatology.

Assessment of Coronary Risk Based on Cumulative Exposure to Lipids in Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, D. Ibañez, 2013, The Journal of Rheumatology.

Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic Cohort

D. Gladman, M. Urowitz, D. Ibañez, 2020, The Journal of Rheumatology.

Switching Treatment Between Mycophenolate Mofetil and Azathioprine in Lupus Patients: Indications and Outcomes

D. Gladman, M. Urowitz, D. Ibañez, 2014, Arthritis care & research.

Long‐term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus

D. Gladman, M. Urowitz, D. Ibañez, 2012, Arthritis care & research.

Is There an Advantage Over SF-36 with a Quality of Life Measure That Is Specific to Systemic Lupus Erythematosus?

D. Gladman, M. Urowitz, D. Ibañez, 2011, The Journal of Rheumatology.

Complications The Effect of Lupus Nephritis on Pregnancy Outcome and Fetal and Maternal

D. Gladman, D. Ibañez, Urowitz, 2010 .

Isolated Hematuria and Sterile Pyuria May Indicate Systemic Lupus Erythematosus Activity

D. Gladman, M. Urowitz, D. Ibañez, 2015, The Journal of Rheumatology.

Risk Factors for Development of Coronary Artery Disease in Women with Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, R. Goldberg, 2009, The Journal of Rheumatology.

Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus

E. Silverman, D. Gladman, M. Urowitz, 2008, Lupus.

Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus.

D. Gladman, M. Urowitz, M. Urowitz, 2001, The Journal of rheumatology.

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus

D. Gladman, C. Gordon, D. Isenberg, 2010, Arthritis care & research.

The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients

D. Gladman, M. Urowitz, M. Urowitz, 2014, Lupus.

Myocardial Perfusion Imaging in Assessing Risk of Coronary Events in Patients with Systemic Lupus Erythematosus

I. Bruce, D. Gladman, M. Urowitz, 2009, The Journal of Rheumatology.

Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease

D. Gladman, M. Urowitz, M. Urowitz, 2009, Lupus.

Changes in Quality of Life in the First 5 Years of Disease in a Multicenter Cohort of Patients With Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, C. Gordon, 2014, Arthritis care & research.

Is There an Advantage Over SF-36 with a Quality of Life Measure That Is Specific to Systemic Lupus Erythematosus?

D. Gladman, M. Urowitz, D. Ibañez, 2011, The Journal of Rheumatology.

Recommendations for Frequency of Visits to Monitor Systemic Lupus Erythematosus in Asymptomatic Patients: Data from an Observational Cohort Study

D. Gladman, M. Urowitz, D. Ibañez, 2013, The Journal of Rheumatology.

Monoclonal gammopathy in systemic lupus erythematosus

D. Gladman, M. Urowitz, D. Ibañez, 2007, Lupus.

Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, J. Wither, 2015, The Journal of Rheumatology.

The Active Clinically Quiescent Systemic Lupus Erythematosus Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically

M. Urowitz, J. Wither, D. Ibañez, 2015 .

Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus.

D. Gladman, M. Urowitz, D. Ibañez, 2009, Arthritis and rheumatism.